FDA, DoD formalize medical product development deal

The FDA said last Friday that it and the U.S. Department of Defense’s Office of Health Affairs inked a Memorandum of Understanding to support medical product development  intended to support military personnel. The deal creates a framework through which the FDA and DOD can implement “enhanced engagements” that were part of a law passed by Congress last year. “We’re extremely grateful to the men and women who defend our nation, often at great personal risk and sacrifice. It’s our honor and duty to support our military personnel by ensuring they have access to safe and effective medical products – especially products that meet the unique needs and settings in which soldiers may require medical treatment. The FDA has already been working closely with the DoD to identify opportunities to expedite availability of medical products, particularly those products used to treat injuries in battlefield settings. For example, as noted below, the Emergency Use Authorization for French freeze-dried plasma that was issued earlier this year. Our close collaboration with DoD has helped us target and more efficiently address DoD’s immediate product priorities and foster development and review of these products in the most streamlined manner possible. We are looking forward to additional partnership opportunities under the MOU,” FDA Commissioner Dr. Scott Gottlieb said in a press release. The FDA will work closely with the DoD to explore how to support and prom...
Source: Mass Device - Category: Medical Devices Authors: Tags: Featured Food & Drug Administration (FDA) Research & Development U.S. Department of Defense Source Type: news